DR. AGARWAL'S EYE HOSP L Share Price

₹ 5,425.00

+₹107.50 (2.02%)

Last updated 02 Nov, 2026, 15:29 IST

NSE: DRAGARWQ

DR. AGARWAL'S EYE HOSP L Share Price Today

As of 3 Nov 2026, DR. AGARWAL'S EYE HOSP L share price is ₹5,425.00. The stock opened at ₹5,318.50, compared to its previous close of ₹5,317.50. During today's trading session, DR. AGARWAL'S EYE HOSP L share price moved in the range of ₹5,221.00 to ₹5,460.00, with an average price of ₹5,340.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,600.00 and a high of ₹6,059.70. On the performance front, DR. AGARWAL'S EYE HOSP L share price has increased by 8.89% over the last six months and is up 8.13% on a year-on-year basis.

₹5,221.00

2.02% up today

₹5,460.00

1D LOW

1D HIGH

DR. AGARWAL'S EYE HOSP L Stock Insights

Stock Performance

OutperformingBeat Nifty by 1.74 % in last 1 month

Shareholding Pattern

DIIDII increased stake by 19.83%

Shareholding Pattern

FIIFII decreased stake by 0.84%

DR. AGARWAL'S EYE HOSP L Stock Insights

Stock Performance

OutperformingBeat Nifty by 1.74 % in last 1 month

Shareholding Pattern

DIIDII increased stake by 19.83%

Shareholding Pattern

FIIFII decreased stake by 0.84%

DR. AGARWAL'S EYE HOSP L stock performance
Open	₹5,318.50
High	₹5,460.00
Low	₹5,221.00
Prev. close	₹5,317.50

DR. AGARWAL'S EYE HOSP L trading activity
Volume	1,146
Average traded price	₹5,320.70
Last traded time	03:29:41 02 Nov
Last traded quantity	3

₹4,254.00₹6,381.00

Circuit Low

Circuit High

₹4,600.00₹6,059.70

52-Week Low

52-Week High

Circuit

₹4,254.00

₹6,381.00

52-week

₹4,600.00

₹6,059.70

Mkt Cap Cr

2,551.81

P/E

33.48

P/B

7.37

ROA

9.94%

ROE

20.24%

ROCE

15.63%

Quick Ratio

1.1

EV/EBITDA

18.24

Mkt Cap Cr

2,551.81

P/E

33.48

P/B

7.37

ROA

9.94%

ROE

20.24%

ROCE

15.63%

Quick Ratio

1.1

EV/EBITDA

18.24

Based on fundamentals, this stock's

Performance

Excellent

Dr Agarwal's Eye outperforming all market indices

Valuation

Fairly Valued

Dr Agarwal's Eye appears to be fairly valued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Apollo Hospitals	1,20,779.11	55.61	12.74	9.79%	20.48%	17.27%	0.98	30.42
MANIPAL HEALTH ENTERPRI L	87,926.39	97.02	5.35	4.07%	10.59%	9.51%	1.17	34.66
Max Healthcare	83,704.68	60.65	7.39	7.37%	12.18%	13.24%	0.84	33.68
Aster DM Healthcare	59,570.09	164.28	14.16	4.47%	8.48%	10.1%	1.9	66.59
Fortis Healthcare	58,116.68	54.29	5.87	6.7%	10.53%	12.56%	0.8	28.03
Narayana Hrudayalaya	35,143.93	43.04	7.74	6.43%	17.17%	12.26%	2.07	19.68
Global Health	34,121.90	61.78	8.61	9.35%	14.05%	15.26%	2.54	32.32
Dr. Lal Path Labs	31,997.02	58.57	12.76	17.36%	20.13%	25.56%	3.38	34.28
KRISHNA INST OF MED SCI L	29,480.26	151.6	7.87	2.51%	10.74%	7.99%	0.68	39.1
Syngene International	16,251.72	87.33	3.34	2.79%	5.47%	7.06%	1.29	22.34

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

DR. AGARWAL'S EYE HOSP L Company Background

ISIN

INE934C01018

Sector Market Cap

₹ 2,551.81 Cr

Dr. Agarwal's Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.

DR. AGARWAL'S EYE HOSP L Financial Highlights

Revenue: DR. AGARWAL'S EYE HOSP L reported revenue of ₹476.69 crore in FY26 vs ₹402.24 crore in FY25. It showed an increase of 18.51% on a yearly basis.
Operating Profit: DR. AGARWAL'S EYE HOSP L reported an operating profit of ₹93.61 crore in FY26 vs ₹70.70 crore in FY25. It showed an increase of 32.40% on a year-on-year basis.
Net Profit: DR. AGARWAL'S EYE HOSP L reported a net profit of ₹70.10 crore in FY26 vs ₹54.65 crore in FY25. It showed an increase of 28.27% on a yearly basis.

DR. AGARWAL'S EYE HOSP L Quarterly Result Highlights

DR. AGARWAL'S EYE HOSP L reported revenue of ₹144.93 crore in Jun 2026, compared with ₹121.58 crore in Mar 2026, representing an increase of 19.21% on a quarter-on-quarter (QoQ) basis.
DR. AGARWAL'S EYE HOSP L reported an operating profit of ₹30.96 crore in Jun 2026, compared with ₹21.25 crore in Mar 2026, representing an increase of 45.69% on a quarter-on-quarter (QoQ) basis.
DR. AGARWAL'S EYE HOSP L reported a profit of ₹23.38 crore in Jun 2026, compared with ₹16.24 crore in Mar 2026, reflecting an increase of 43.97% on a QoQ basis.
The earnings per share (EPS) of DR. AGARWAL'S EYE HOSP L stood at ₹147.02 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

72.67%

FII

2.22%

Other DII

2.42%

Retail and other

22.57%

Mutual funds

0.12%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	1.82%
Mar 2026	2.20%
Jun 2026	2.24%
Sep 2026	2.22%

DR. AGARWAL'S EYE HOSP L Investment Returns

1 day

+1.77%

1 week

+4.71%

1 month

+4.89%

1 year

+8.13%

3 years

+8.13%

5 years

+8.13%

DR. AGARWAL'S EYE HOSP L Share Price History

DR. AGARWAL'S EYE HOSP L share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹5,318.50 / ₹5,425.00	+2.02%
30 Oct 26	₹5,235.00 / ₹5,317.50	+0.34%
29 Oct 26	₹5,145.00 / ₹5,299.50	+3.67%
28 Oct 26	₹5,200.00 / ₹5,112.00	-2.50%
27 Oct 26	₹5,132.50 / ₹5,243.00	+1.45%
26 Oct 26	₹5,010.50 / ₹5,168.00	+2.23%
23 Oct 26	₹4,984.00 / ₹5,055.50	+1.95%
22 Oct 26	₹5,005.00 / ₹4,959.00	-1.03%
21 Oct 26	₹5,077.50 / ₹5,010.50	-1.32%
19 Oct 26	₹5,114.00 / ₹5,077.50	+0.01%

DR. AGARWAL'S EYE HOSP L Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹470.87	₹397.15	₹319.30	₹268.10
Other Income	₹5.82	₹5.09	₹4.97	₹1.55
Total Revenue	₹476.69	₹402.24	₹324.27	₹269.65
Total Expenses	₹383.08	₹331.54	₹262.02	₹220.25
Profit Before Tax	₹93.61	₹70.70	₹62.25	₹49.40
Tax	₹23.51	₹16.05	₹15.89	₹12.48
Profit After Tax	₹70.10	₹54.65	₹46.36	₹36.92
EPS - Basic	₹147.02	₹116.28	₹98.64	₹78.55
EPS - Diluted	₹147.02	₹116.28	₹98.64	₹78.55

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹93.61	₹70.70	₹62.25	₹49.40
Income before WC changes	₹148.05	₹120.70	₹93.40	₹76.20
Change in Assets	-₹9.25	-₹7.16	-₹8.90	₹1.87
Change in Liabilities	₹15.38	₹0.15	₹18.88	₹3.07
Change in WC	₹6.13	-₹7.01	₹9.98	₹4.94
Cash flow from Operations	₹145.14	₹93.56	₹89.77	₹69.62
Cash flow from Investing	-₹173.53	-₹132.78	-₹70.04	-₹70.61
Cash flow from Financing	₹24.78	₹16.58	-₹14.23	₹0.26
Total Cash Flow	-₹3.61	-₹22.64	₹5.50	-₹0.73
Cash (Start of the year)	₹10.24	₹32.88	₹27.38	₹28.11
Cash (End of the year)	₹6.63	₹10.24	₹32.88	₹27.38

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹629.92	₹558.61	₹435.93	₹343.40
Current Assets	₹136.54	₹54.71	₹59.83	₹46.54
Total Assets	₹766.46	₹613.32	₹495.76	₹389.94
Current Liabilities	₹111.38	₹86.98	₹80.77	₹55.08
Net Current Asset	₹25.16	-₹32.27	-₹20.94	-₹8.54
Non-Current Liabilities	₹308.78	₹316.73	₹257.84	₹221.52
Equity Capital	₹346.30	₹209.61	₹157.15	₹113.34
Total Equity & Liabilities	₹766.46	₹613.32	₹495.76	₹389.94